DISCOVERY LABORATORIES, INC. Warrant To Purchase Common StockDiscovery Laboratories Inc /De/ • May 8th, 2009 • Biological products, (no disgnostic substances) • New York
Discovery Laboratories, Inc., a Delaware corporation (the "Company"), hereby certifies that, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, [INVESTOR NAME], the registered holder hereof or its permitted assigns (the "Holder"), is entitled, subject to the terms set forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Common Stock (including any Warrants to Purchase Common Stock issued in exchange, transfer or replacement hereof, the "Warrant"), at any time or times on or after the date hereof (the “Exercisability Date”), but not after 11:59 p.m., New York time, on the Expiration Date (as defined below), [______________ (_____________)]1 fully paid nonassessable shares of Common Stock (as defined below) (the "Warrant Shares"). Except as otherwise defined herein, capitalized terms in this Warrant shall have the meanings set forth in Section 15. This
14,000,000 Shares of Common Stock and Warrants to Purchase up to 7,000,000 Shares of Common Stock DISCOVERY LABORATORIES, INC. Common Stock (par value $0.001) PLACEMENT AGENT AGREEMENTAgent Agreement • May 8th, 2009 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
SUBSCRIPTION AGREEMENTSubscription Agreement • May 8th, 2009 • Discovery Laboratories Inc /De/ • Biological products, (no disgnostic substances) • New York
The undersigned (the “Investor”) hereby confirms its agreement with Discovery Laboratories, Inc., a Delaware corporation (the “Company”), as follows:
